Exploring interlinkages between national and sectoral innovation systems for rapid technological catch-up: Case of indian biopharmaceutical industry

Technology Analysis and Strategic Management

Volumn 19, Issue 5, 2007, Pages 643-657

  Chaturvedi, Sachin ^a  

^a India Habitat Centre   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; ECONOMIC GROWTH; INNOVATION; PHARMACEUTICAL INDUSTRY; TECHNOLOGY POLICY;

ASIA; EURASIA; INDIA; SOUTH ASIA;

EID: 34548559151     PISSN: 09537325     EISSN: 14653990     Source Type: Journal    
DOI: 10.1080/09537320701521408     Document Type: Article

References (52)

1. Biopharmaceuticals are therapeutic or preventative medicines that are derived from living cells, using recombinant DNA technology. Conventional pharmaceuticals are generally small molecules, whereas biopharmaceuticals are typically proteins, peptides, nucleic acids or inactivated viruses/bacteria. The biopharmaceuticals include insulin, hepatitis B vaccine, erythropoietin, human growth hormones.
2. S. Dogra, The biopharma boom, Pharma Express, 31 October 2006.
3. M. Quéré, Knowledge dynamics: Biotechnology incursion into the pharmaceutical industry, Industry and Innovation, 10(3), 2003, pp. 255-273.
4. R. Nelson & N. Rosenberg, Technical innovation and national systems, in: R. Nelson (Ed.) National Systems of Innovation: A Comparative Analysis (Oxford, Oxford University Press, 1993), pp. 3-21.
5. B. Carlsson (Ed.), Technological Systems and Industrial Dynamics (Boston, MA, Kluwer Academic, 1997).
6. A. Saxenian, Regional Advantage: Culture and Competition in Silicon Valley and Route 128 (Cambridge, Cambridge University Press, 1999)
7. P. Cooke, Business processes in regional innovation systems in the European Union, in: Z. Acs (Ed.) Regional Innovation, Knowledge and Global Change (London, Pinter, 2000), pp. 53-71
8. H. J. Braczyk, P. Cooke & M. Heideareich (Eds), Regional Innovation Systems (London, UCL Press, 1998).
9. F. Malerba, Innovation and the evolution of industries, CESPRI Working Paper No. 170, Centro di Ricerca sui Processi di Innovazione e Internazionalizzazione, July 2005
10. F. Malerba, Sectoral systems of innovation and production, Research Policy 31, 2002, pp. 247-264.
11. S. Bartholomew, National system of biotechnology innovation: Complex interdependence in the global system, Journal of International Business Studies, 28(2), 1997, pp. 241-266
12. J. Senker, European Biotechnology Innovation System (EBIS): Analysis of the biopharmaceutical sector, Project Report submitted to EC, DG XII, 2001.
13. M. McKelvey & L. Orsenigo, Pharmaceuticals as a sectoral innovation system, University of Brescia and CESPRI, Bocconi University, Milan, A Miemo, 2001
14. F. Malerba & L. Orsenigo, Innovation and market structure in the dynamics of the pharmaceutical industry and biotechnology: Towards a history-friendly model, Industrial and Corporate Change, 11(4), 2002, pp. 667-703.
15. D. Archibugi, J. Howells & J. Michie, Innovation systems in a global economy, Technology Analysis and Strategic Management, 11(4), 1999, pp. 527-539.
16. McKelvey & Orsenigo, op. cit., Ref. 9.
17. G. P. Pisano, Can science be a business? Lessons from biotech, Harvard Business Review, 84(10), October 2006, pp. 114-125.
18. Nelson & Rosenberg, op. cit., Ref. 4.
19. B.A. Lundvall, Introduction, in: B. A. Lundvall (Ed.) National Systems of Innovation. Towards a Theory of Innovation and Interactive Learning (London, Pinter, 1992), pp. 1-19
20. R. Kaiser & P. Heiko, 'The reconfiguration of national innovation systems - the example of German biotechnology, Research Policy, 33, 2004, pp. 395-408.
21. Malerba, op. cit., Ref. 7.
22. Lundvall, op. cit., Ref. 14.
23. Kaiser et al., op. cit., Ref. 14.
24. G. P. Sinha, Government to set up 5 institutes to boost pharma R&D, The Economic Times, 8 December 2006.
25. MoEF, Report of the Task Force on Recombinant Pharma. Ministry of Environment and Forests, Government of India, August, 2005.
26. Ibid.
27. K. S. Jayaraman, India sets its sights on global health care market, Nature Medicine, 9, 2003, p. 377.
28. The Times of India, 9 September 2001.
29. DST, Annual Report, Ministry of Science and Technology, Department of Science and Technology, Government of India, New Delhi, 2005.
30. The Reserve Bank of India governs the investment and flow of foreign currency in and out of India.
31. S. Sethi, Venture capital reforms: Give me more on the platter, The Economic Times, 31 January 2001.
32. Based on ICICI web page.
33. B. Bowonder & S. Mani, Venture capital and innovation: The Indian experience, 2002, Paper presented at the International Conference on 'Financial Systems, Corporate Investment in Innovation and Venture Capital', UNU/INTECH and EU-DG Research, Brussels, 7-8 November 2002.
34. Indian Planning Commission, Sixth Five Year Plan, 1980-85, New Delhi, Planning Commission, p. 326.
35. Department of Biotechnology,Annual Report 1987-88, Ministry of Science andTechnology,Government of India, New Delhi, 1988
36. Department of Biotechnology, Annual Report 1997-98, Ministry of Science and Technology, Government of India, New Delhi, 1998
37. Department of Biotechnology, Annual Report 2001-02, Ministry of Science and Technology, Government of India, New Delhi, 2002.
38. Personal communication with, ICMR officials, New Delhi.
39. Department of Biotechnology, Annual Report 2000-2001, Ministry of Science and Technology, Government of India, New Delhi, 2001.
40. www.ibab.ac.in (accessed 21 May 2007).
41. Indian Express, 9 January 2002.
42. Business World, Reliance Life goes shopping, Business World, New Delhi, 8 January 2007
43. Business Standard, 'Reliance Life closes in on #1 bn. US buy', Business Standard, New Delhi, 21 December 2006.
44. The Economic Times, 29 July 29 2001.
45. H. Rajappa, rDNA, the hot new biopharma favourite, BioSpectrum, 15 February 2007.
46. Personal communication with Chairperson, CII: Task Force on Biotechnology.
47. K. S. Sinha, Pharma majors take does of new molecule R&D, Business Standard, New Delhi, 19 February 2007.
48. The Economic Times, 18 July 2001.
49. BioSpectrum, Dr Bhan moots Indo-US innovation forum to spur growth in biotech, 6 January 2006.
50. Malerba, op. cit., Ref. 7.
51. S. Chaturvedi, Dynamics of biotechnology research and industry in India: statistics, perspectives and key policy issues, Science, Technology and IndustryWorking Paper No. 2005/6, OECD, 2005. Updated from Annual Report of 2006/07, Department of Biotechnology, Government of India.
52. Senker, op. cit., Ref. 8.